'김갑성' 기자의 전체기사
-
TVM Capital Healthcare Announces First Closing of its USD 150…
SINGAPORE, Sept. 11, 2025 -- TVM Capital Healthcare, a global private equity investor and operator specialized in healthcare growth capital across emerging markets, today announced the first closing of its USD 150 million TVM Healthcare Southeast Asia Fund ("SEA Fund"). The SEA Fund is the third generation of TVM Capital Healthcare funds and builds on the firm's nearly 40 years of global healthcare investment and operator experience, including over 15 years of scaling healthcare companies across the Middle East and Southeast Asia. TVM Capital Healthcare has a strong t
- 김갑성 기자
- 2025-09-11 02:39
-
Three global institutions win million dollar prize for the 2025 An…
[ 메디채널 김갑성 기자 ] Valued at €1 million, it is the world's largest award in the field of vision, recognising work that combines scientific excellence, global impact, and a commitment to equity in eyesight. The Fred Hollows Foundation has restored sight to more than 3 million people in more than 25 countries across Asia, Africa, and Oceania. The Lions Clubs International Foundation (LCIF) has provided eye health services to more than 544 million people in 118 countries, performing over nine million cataract surgeries. The International Agency for the Prevention of Blindness (IAPB) stands o
- 김갑성 기자
- 2025-09-10 23:41
-
Altair and Wichita State University's NIAR Sign MoU to Accelerate…
Collaboration will expand digital twin adoption, empower aerospace startups, and speed up product development and certification processes TROY, Mich., Sept. 10, 2025 -- Altair, a global leader in computational intelligence, and Wichita State University's (WSU) National Institute for Aviation Research (NIAR), one of the world's leading aerospace research institutions, have signed a memorandum of understanding (MoU) to advance innovation across the aerospace and defense industries. "NIAR is a global leader in aerospace research, and this partnership paves the
- 김갑성 기자
- 2025-09-10 23:16
-
Shineco Achieves Mass Production of High-Purity Physical P…
BEIJING, Sept. 10, 2025 -- Shineco Inc. (NASDAQ: SISI) ("Shineco" or the "Company"), a leading developer of induced pluripotent stem cell (iPSC) technology platforms, today announced that its subsidiary, Fuzhou Meidashan Biotechnology Co., Ltd., has successfully achieved large-scale production of high-purity, highly active free-form soybean phospholipids. This breakthrough was made possible through its proprietary APCC-UF pure physical extraction technology, overcoming a persistent global technical challenge in the field. Testing by multiple authoritative institutions conf
- 김갑성 기자
- 2025-09-10 21:30
-
C-Ray Therapeutics Supports Mednovo's Phase III Clinical T…
CHENGDU, China, Sept. 10, 2025 -- August 22, 2025, Mednovo Group Co., Ltd. ("Mednovo") announced that the first patient has been successfully dosed in its Phase III clinical trial of Lutetium [177Lu] Oxodotreotide Injection, a Class 3 targeted radiotherapeutic drug. As the exclusive clinical supply and manufacturing partner, C-Ray Therapeutics delivered end-to-end support for this milestone, including technology transfer, clinical batch production, quality release, and logistics. Leveraging China's first fully automated radiopharmaceutical production line built to global cGMP
- 김갑성 기자
- 2025-09-10 21:30
-
Imaging Endpoints Announces Patent Application for AI Revi…
SCOTTSDALE, Ariz., Sept. 10, 2025 -- Imaging Endpoints (IE), the global leader in Imaging CRO technologies and services for oncology trials, announced the filing of a provisional patent application for its revolutionary AI enhanced Imaging Review Charter (IRC) system. This innovative AIRC System™ is designed to enhance highly customized IRCs for clinical trials, setting new standards in the industry. Imaging Endpoints is the scientific leader in customizing and optimizing image acquisition and analysis for clinical trials in oncology, with the most sophisticated approac
- 김갑성 기자
- 2025-09-10 21:00
-
LakeShore Biopharma Announces Appointment of Indepen…
BEIJING, Sept. 10, 2025 -- LakeShore Biopharma Co., Ltd (Nasdaq: LSB, "LakeShore Biopharma" or the "Company"), a global biopharmaceutical company dedicated to discovering, developing, manufacturing, and delivering new generations of vaccines and therapeutic biologics for infectious diseases and cancer, today announced that the independent special committee (the "Special Committee") of the Company's board of directors (the "Board"), formed to evaluate and consider the previously announced revised preliminary non-binding proposal letter dated August 26,
- 김갑성 기자
- 2025-09-10 20:10
-
Optain Health Closes $26 Million Series A to Bring Oculomics to…
Insight Partners leads; seven major U.S. health systems join. Funding accelerates the global rollout of Optain's advanced robotic retinal imaging, AI, and teleophthalmology platform. NEW YORK, Sept. 10, 2025 -- Optain Health, a healthcare technology company applying artificial intelligence (AI), robotic retinal imaging, and teleophthalmology to detect eye and systemic disease earlier, today announced the close of an oversubscribed $26 million Series A. The raise was led by global software investor Insight Partners with participation from existing investors. A single, non
- 김갑성 기자
- 2025-09-10 20:00
-
Strider Technologies Announces Partnership with NATO's D…
[ 메디채널 김갑성 기자 ] NATO DIANA will leverage Strider's strategic intelligence as economic security tool LONDON, Sept. 10, 2025 -- Strider Technologies, Inc. the leading provider of strategic intelligence, today announced its new partnership with NATO's Defence Innovation Accelerator for the North Atlantic (DIANA). Under this partnership, Strider will deliver its economic security capabilities to aid NATO DIANA in identifying contractual and supply chain risks from strategic competitors as set out in the NATO 2022 Strategic Concept. Strider's strategic intelligence will also be us
- 김갑성 기자
- 2025-09-10 16:00
-
UltiMaker、SシリーズのSecure Lineを発表、高セキュリティ・オンデマンド生産…
Secure Lineは、あらゆる環境において積層造形を最前線の戦術的能力へと変革します。 ニューヨークおよびゲルデルマルセン（オランダ）, 2025年9月10日 -- 防衛、製造、教育分野における3Dプリンティングの世界的リーダーであるUltiMakerは本日、防衛および高セキュリティ環境向けに設計された新たなSecure Line 3Dプリンティング製品の発売を発表しました。発売当初の主力製品は、UltiMaker S6 SecureとUltiMaker S8 Secureの2機種です。これらは陸上、海上、航空作戦において信頼性の高いオンデマンド生産能力を提供するために設計された堅牢なソリューションです。 安全で耐障害性があり、分散型の製造に対する需要が高まる中、Secure Lineは積層造形を配備可能な戦術資産へと転換する上で大きな前進を意味します。UltiMakerの実績あるプラットフォームを基盤とするS6 SecureおよびS8 Secureは、産業レベルの性能と、現代の防衛IT基準を満たすために設計された強化されたセキュリティ機能を兼ね備えています。 「Secure Lineは、積層造形技術を防衛組織にとって信頼性が高く配備可能な資産とする戦略的飛躍を体現しています」と、UltiMakerのE
- 김갑성 기자
- 2025-09-10 14:39
- 1포리프 굿마팻 (누바디 굿바이 마이팻) 다이어트 건강기능식품 출시
- 22021년 식품분석전문가 1급/2급 검정자격시험 안내
- 3투썸플레이스, 초콜릿 애프리콧 무스 출시
- 4만성질환자들의 유료독감백신접종에 정책적인 배려가 필요하다
- 5아임웹, CRM 기능 출시… 고객 행동 데이터 기반 마케팅 지원
- 6하만카돈, AURA STUDIO 4 블루투스 스피커 출시
- 7대구오페라하우스 - 20주년 기념 골든 보이스 시리즈Ⅲ, 테너 콘서트
- 82021년 대학생기자단 모집
- 9대한약물영양의학회 2020년 추계학술대회
- 10대한영양제처방학회 춘계학술대회 성황리에 마쳐
2025-10-19_SUN
- Multitude Therapeutics Announces Encouraging Interim Phase I/II Results from Ongoing First-in-Human Study Evaluating its MUC18-directed Antibody-Drug-Conjugate, AMT-253, in Melanoma and Other Advanced Solid Tumors at the 2025 ESMO Annual Meeting 15:00
- Case Report | Preliminary Clinical Data of CARsgen's Allogeneic BCMA CAR-T Product CT0596 for the Treatment of Primary Plasma Cell Leukemia 14:00
- From Wellbeing to Academics: Why HK Parents Are Hitting Pause on Kids' Social Media and Device Use 13:00
- 내면의 조화를 발견하세요: '원더풀 인도네시아 웰니스 페스티벌 2025' 개최 01:50
- 제2회 마나르 아부다비 출품 작가 명단 공개 00:48
- 중국-피지 어업 협력, 섬나라 경제 활력 끌어올리다 00:00
2025-10-18_SAT
발행인 : 최희정 | 편집인 : 김갑성 |
등록번호: 서울특별시 아53302 | 등록일 2020-09-25 | 전화번호 02-565-7119 |
주소 : 서울특별시 강남구 영동대로 602, 6층 E115 (삼성동)
Copyright @메디채널 Corp. All rights reserved.
UPDATE: 2025년 10월 19일 16시 40분